SpineVision, a France-based commercial-stage medical device company, has raised a $10 million financing led by Omega Funds, with participation from Alto Invest, Midi Capital and an individual investor. The proceeds will help expand commercial activities in Europe. Founded in 1999, SpineVision designs, develops and markets products for the surgical treatment of spine disorders.
